Skip to main content
AVECHO BIOTECHNOLOGY LIMITED logo

AVECHO BIOTECHNOLOGY LIMITED — Investor Relations & Filings

Ticker · AVE ISIN · AU0000047441 LEI · 529900FA9G9T82C2LV25 ASX Manufacturing
Open in API
Filings indexed 881 across all filing types
Latest filing 2012-05-22 Regulatory Filings
Country AU Australia
Listing ASX AVE

About AVECHO BIOTECHNOLOGY LIMITED

https://avecho.com.au/

Avecho Biotechnology Limited develops and commercializes human and animal health products using its proprietary drug delivery system, Tocopheryl Phosphate Mixture (TPM®). Derived from Vitamin E, TPM® is designed to enhance the solubility and absorption of active ingredients through the skin and digestive tract. The company focuses on applying this technology to pharmaceuticals, nutraceuticals, and animal health sectors. A primary area of development includes medicinal cannabis, where Avecho has produced high-bioavailability cannabidiol (CBD) softgel capsules for therapeutic use. The company’s portfolio also includes applications in pain management and dermatology, leveraging TPM® to improve the delivery of poorly soluble molecules and enhance the efficacy of existing treatments.

Recent filings

Filing Released Lang Actions
Phosphagenics Engages Labtec for Final Patch Design 2 pages 43.6KB
Regulatory Filings Classification · 95% confidence The document is a company announcement providing an update on the development of a pharmaceutical product (a transdermal TPM/oxycodone patch). It discusses the engagement of a manufacturing partner, the status of product design, clinical trial plans, and market analysis. There are no financial statements, regulatory filings, voting results, or detailed financial data. The document is relatively short (3866 characters) and serves as a business update rather than a formal financial or regulatory report. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is best classified as a general company announcement about business progress and development activities, which falls under Regulatory Filings (RNS) as a fallback category for miscellaneous announcements that do not fit other specific categories.
2012-05-22 English
CEO Presentation - Bell Potter Life Sciences Conference 22 pages 996.1KB
Investor Presentation Classification · 100% confidence The document is a detailed presentation delivered by the CEO of Phosphagenics at the Bell Potter Life Sciences Conference. It includes company overview, technology description, product pipeline, partnerships, management team, and market positioning. The content is structured as a slide presentation with forward-looking statements and detailed business and technology information. It is explicitly described as a presentation to investors and market participants at a conference. There are no financial statements, audit opinions, or regulatory filings included. The document is not an earnings release or annual/interim report but a comprehensive investor presentation focusing on strategy, technology, and market position. Therefore, the appropriate classification is Investor Presentation (IP). The document length (15,000 characters) and content confirm it is the presentation itself, not just an announcement of a report.
2012-05-22 English
Phosphagenics to Launch BodyShaper in UK Market 2 pages 64.8KB
Regulatory Filings Classification · 90% confidence The document is a company announcement about the launch of a product (BodyShaper) in the UK market. It contains promotional and marketing information, contact details, and background about the company and the retail partner. There is no financial data, regulatory filing references, voting results, or management changes. The document is short (3342 characters) and serves as a press release or marketing announcement rather than a financial or regulatory report. It does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. Given the content and nature, the best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2012-05-20 English
POH adds David Jones as retail partner for Elixia products 2 pages 41.0KB
Regulatory Filings Classification · 95% confidence The document is a company announcement dated 8 May 2012 about Phosphagenics adding David Jones as a retail partner. It discusses product distribution and retail expansion but contains no financial data, regulatory references, or report filings. The length is short (2577 characters) and it is clearly a business update rather than a financial report or regulatory filing. It does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. It is a general corporate announcement about business development and retail partnerships, which does not match any specific filing category. The closest fit is Regulatory Filings (RNS) as a general announcement that does not fit other categories.
2012-05-07 English
App3B - Exercise Options - Reconcilation Non-listed security 32 pages 280.4KB
Share Issue/Capital Change Classification · 95% confidence The document is a detailed announcement regarding the exercise of options and the issue of new shares by the company Phosphagenics Limited. It includes specifics about the number of shares issued, exercise prices, reconciliation of non-quoted securities, details of employee share option plans, conditional rights plans, and an Appendix 3B form which is a standard new issue announcement form used for notifying the Australian Securities Exchange (ASX) about new securities issued and their quotation. The document is not a financial report, earnings release, or management discussion but rather a formal announcement of share issuance and related securities information. This fits the definition of a Share Issue/Capital Change announcement (SHA). The document length and detail confirm it is the announcement itself, not just a brief notice or a report publication announcement.
2012-05-03 English
Annual Report and Notice of AGM - Proxy Form 110 pages 2.1MB
Regulatory Filings
2012-04-19 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.